linotropic effect of acute exendin-4 ad-ministered to humans: comparison ofnondiabetic state to type 2 diabetes. J Clin Endocrinol Metab 87:1282–1290, 2002 27. Go ¨ke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Go ¨ke B: Exendin-4 is a high potency agonist and truncated ex-endin-(9-39)-amide an antagonist at theglucagon-like peptide 1-(7-36)-amide re-ceptor of insulin-secreting beta-cells.J Biol Chem 268:19650–19655, 1993 28. Nielsen LL, Young AA, Parkes D: Pharma- cology of exenatide (synthetic exendin-4): a potential therapeutic for improvedglycemic control of type 2 diabetes. RegPept117:77–88, 2004 29. Szayna M, Doyle ME, Betkey JA, Hollo- way HW, Spencer RGS, Greig NH, EganJM: Exendin-4 decelerates food intake,weight gain, and fat deposition in Zuckerrats. Endocrinol 141:1936–1941, 2000 30. Willms B, Ruge D: Comparison of acarbose